These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 33210958)
1. An update on endotoxin neutralization strategies in Gram-negative bacterial infections. Brandenburg K; Schromm AB; Weindl G; Heinbockel L; Correa W; Mauss K; Martinez de Tejada G; Garidel P Expert Rev Anti Infect Ther; 2021 Apr; 19(4):495-517. PubMed ID: 33210958 [TBL] [Abstract][Full Text] [Related]
2. Anti-Endotoxin 9-Meric Peptide with Therapeutic Potential for the Treatment of Endotoxemia. Krishnan M; Choi J; Choi S; Kim Y J Microbiol Biotechnol; 2021 Jan; 31(1):25-32. PubMed ID: 33263333 [TBL] [Abstract][Full Text] [Related]
5. De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs. Bhattacharjya S Curr Med Chem; 2010; 17(27):3080-93. PubMed ID: 20629624 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis. Chockalingam A; Zarlenga DS; Bannerman DD Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic induced endotoxin release and clinical sepsis: a review. Holzheimer RG J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361 [TBL] [Abstract][Full Text] [Related]
8. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis. Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054 [TBL] [Abstract][Full Text] [Related]
9. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis. Morrison DC; Bucklin SE Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044 [TBL] [Abstract][Full Text] [Related]
10. Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides. Martinez de Tejada G; Heinbockel L; Ferrer-Espada R; Heine H; Alexander C; Bárcena-Varela S; Goldmann T; Correa W; Wiesmüller KH; Gisch N; Sánchez-Gómez S; Fukuoka S; Schürholz T; Gutsmann T; Brandenburg K Sci Rep; 2015 Sep; 5():14292. PubMed ID: 26390973 [TBL] [Abstract][Full Text] [Related]
11. Developments on antibiotics for multidrug resistant bacterial Gram-negative infections. Voulgaris GL; Voulgari ML; Falagas ME Expert Rev Anti Infect Ther; 2019 Jun; 17(6):387-401. PubMed ID: 31006284 [No Abstract] [Full Text] [Related]
12. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis. Brandenburg K; Heinbockel L; Correa W; Lohner K Biochim Biophys Acta; 2016 May; 1858(5):971-9. PubMed ID: 26801369 [TBL] [Abstract][Full Text] [Related]
13. Endotoxin neutralizing peptides. Jerala R; Porro M Curr Top Med Chem; 2004; 4(11):1173-84. PubMed ID: 15279607 [TBL] [Abstract][Full Text] [Related]
15. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis. Horn DL; Opal SM; Lomastro E Scand J Infect Dis Suppl; 1996; 101():9-13. PubMed ID: 9060045 [TBL] [Abstract][Full Text] [Related]
16. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides. Rosenfeld Y; Lev N; Shai Y Biochemistry; 2010 Feb; 49(5):853-61. PubMed ID: 20058937 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of endotoxin neutralization by synthetic cationic compounds. Andrä J; Gutsmann T; Garidel P; Brandenburg K J Endotoxin Res; 2006; 12(5):261-77. PubMed ID: 17059690 [TBL] [Abstract][Full Text] [Related]
18. Metalloenzyme inhibitors for the treatment of Gram-negative bacterial infections: a patent review (2009-2012). Supuran CT; Carta F; Scozzafava A Expert Opin Ther Pat; 2013 Jul; 23(7):777-88. PubMed ID: 23458841 [TBL] [Abstract][Full Text] [Related]
19. Mastering the Gram-negative bacterial barrier - Chemical approaches to increase bacterial bioavailability of antibiotics. Ropponen HK; Richter R; Hirsch AKH; Lehr CM Adv Drug Deliv Rev; 2021 May; 172():339-360. PubMed ID: 33705882 [TBL] [Abstract][Full Text] [Related]
20. Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein. Kohn FR; Kung AH Infect Immun; 1995 Jan; 63(1):333-9. PubMed ID: 7806373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]